India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution)

Publisher Name :
Date: 01-Dec-2015
No. of pages: 114

Executive Summary

The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders.

Indian Neuropsychiatry Market is a growing market with key players holding dominant positions. The report is classified on the basis of drugs market as well as the devices market. Indian Neuropsychiatry Drugs Market has been growing at an average pace over the last five years on account of rising healthcare expenditure, increasing diagnostic cases of epilepsy and other divisions of neurology. During 2015-20, Indian Neuropsychiatry Drugs Market is anticipated to grow at an increased rate on account of higher cases of Alzheimer patients especially in India. Moreover, consumers are increasingly becoming aware of the healthcare leading to large number of neurology treatments being performed.

The neuropsychiatry devices market is still on the growing path at a CAGR of 9.16% valued at xx million USD by 2020 from xx million USD in 2015 where both domestic and international players are having strong presence in diagnostic and treatment devices, considering more number of patients are being diagnosed using the devices. Also, when the patients are unresponsive to the medicinal drugs, treatment devices are used as a next step of measurement. Due to the fast paced lifestyle of population, increasing number of patients are suffering from neurological disorders and are opting for early treatment, thereby, driving the neuropsychiatric market in India.

According to Azoth Analytics research report, “Indian Neuropsychiatry Market (2015-2020F)” Indian Neuropsychiatry Market is projected to exhibit a CAGR of 9.12% during 2015 - 2020. Few of the leading companies operating in neuropsychiatric drug market in India include Sun Pharma, Intas, Torrent, Sanofi & Abbott whereas companies in devices market in India include RMS India, Nihon Kohden etc.

Scope of the Report

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution) analyses the following aspects of Indian Neuropsychiatry Drugs and Devices Market:


  • Product Overview (Top Companies Market).

  • Market, Drivers & Challenges and Trends.

  • Indian Neuropsychiatry Drugs Market, Size & Forecast.

  • Indian Neuropsychiatry Devices Market, Size & Forecast.


Why You Should Buy This Report?


  • To gain an in-depth understanding of Indian neuropsychiatry market

  • To identify the on-going trends and anticipated growth in the next five years

  • To help industry consultants, neuropsychiatric drugs and devices manufacturers, suppliers and distributors align their market-centric strategies

  • To gain insights on the prevalent market entry strategies in neuropsychiatric market for domestic as well as foreign companies

  • To obtain research based business decision and add weight to presentations and marketing material

  • To gain competitive knowledge of leading players

  • To avail limited customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific needs

India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution)

Table of Contents

1. Research Methodology

2. Product Overview

3. Executive Summary

4. India Economic Profile

5. Product Overview

6. India Neuropsychiatry Industry Structure

7. Neuropsychiatry Outlook in India

8. India Neuropsychiatry Market Outlook
8.1. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.1.1. By Value (Historic 2010-14)
8.1.2. By Value (Forecast 2015E-2020F)
8.1.3. By Drugs, By Value, By Percentage (Estimated 2015E)
8.1.4. By Drugs, By Value, By Percentage (Forecast 2020F)
8.2. India Neuropsychiatry - Total Devices Market Size & Forecast
8.2.1. By Value (Historic 2010-14)
8.2.2. By Value (Forecast 2015E-2020F)
8.2.3. By Region (Estimated 2015E)
8.2.4. By Region (Forecast 2020F)
8.3. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.3.1. By Value (Estimated 2015E)
8.3.2. By Value (Forecast 2020F)
8.4. India Neuropsychiatry -Treatment Devices Market Size & Forecast
8.4.1. By Value (Estimated 2015E)
8.4.2. By Value (Forecast 2020F)
8.5. India Neuropsychiatry Market-Drugs Market Size & Forecast
8.5.1. By Value (Historic 2010-14)
8.5.2. By Value (Forecast 2015E-2020F)
8.5.3. By Region (Estimated 2015E)
8.5.4. By Region (Forecast 2020F)

9. India Neuropsychiatry Market-Policy and Regulatory Landscape

10. India Neuropsychiatry Market- Dynamics
10.1. Drivers
10.2. Challenges

11. India Neuropsychiatry Industry-Trends & Developments

12. India Economic Profile

13.  Neuropsychiatry Industry SWOT Analysis

14. Market Entry Strategies for Foreign Companies

15. India Neuropsychiatry Drug Market Analysis, By Major Drug Manufacturers

16. Competitive Landscape

17. Company Profiling
17.1. Sun Pharmaceutical Industries Ltd.
17.2. Torrent Pharma
17.3. GlaxoSmithKline Pharmaceuticals Ltd.
17.4. Cipla
17.5. Abbott Limited
17.6. Biocon Limited
17.7. Glenmark Pharmaceuticals
17.8. Alembic Ltd.
17.9. Nicholas Primal
17.10. Aventis Pharma Limited

18. Strategic Recommendations

List of Tables

Table 1: Mental Patients Statistics in India, 2012
Table 2: Patients admitted to the Long term Mental Medical care in India, 2012
Table 3: Number of Patients with Mental Disorders, By state, 2013

List of Figures

Figure 1: Neuropsychiatry Devices and their Classification
Figure 2: Indian Neuropsychiatry Devices Industry Structure
Figure 3: India Healthcare Market, By Type of service offered and sector, 2014
Figure 4: India Health Care Delivery System
Figure 5: India Drug Industry Value Chain, By Type of service offered and sector, 2014
Figure 6: Neuropsychiatric Market Value in India, 2010-2014 (in USD Billion)
Figure 7: Healthcare Expenditure Total Percentage of GDP in India (in %)
Figure 8: Per Capita Healthcare Expenditure in India (in USD)
Figure 9: Urban Population in India (in %)
Figure 10: Neuropsychiatric Market Value in India, 2015E-2020F (in USD Billion/INR)
Figure 11: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2015E
Figure 12: Neuropsychiatric Market Value in India, By Drug and Devices, By Percentage, 2020F
Figure 13: Total Neuropsychiatric Devices Market Value in India, 2010-2014 (in USD Million/INR Thousand Crore)
Figure 14: Total Neuropsychiatric Devices Market Value in India, 2015E-2020F (in USD Million/INR Thousand Crore)
Figure 15: Neuropsychiatric Devices Market Value in India, By Region, 2015E
Figure 16: Neuropsychiatric Devices Market Value in India, By, Region 2020F
Figure 17: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment - 2015E
Figure 18: Neuropsychiatric Device Market Value in India, By Diagnostics and Treatment- 2020F
Figure 19: India Neuropsychiatry Drug Market Size , By Value, 2010-2014(USD Billion/INR Thousand Crore)
Figure 20: India Neuropsychiatry Drug Market Size , By Value, 2015E-2020F(USD Billion/INR Thousand Crore)
Figure 21: Neuropsychiatric Drugs Market Value in India, By Region 2015E
Figure 22: Neuropsychiatric Drugs Market Value in India, By Region 2020F
Figure 23: Sales Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 24: EBITDA Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 25: EBIT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 26: PBT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 27: PAT Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 28: Current Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 29: Gross Profit Ratio Comparison of Large Size Neuropsychiatric Market Players, 2011-2015 (INR Crores)
Figure 30: Debt Equity Ratio Comparison of Large Size Neuropsychiatric Market Players , 2011-2015 (INR Crores)
Figure 31: Sales Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 32: EBITDA Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 33: EBIT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 34: PBT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 35: PAT Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 36: Current Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 37: Gross Profit Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 38: Debt Equity Ratio Comparison of Medium Size Companies, 2011-2015 (INR Crores)
Figure 39: Alembic Ltd. Percentage Revenue, By Business Segment (2014 E)
Figure 40: Nicholas Piramal Percentage Revenue, By Business Segment (2015)
Figure 41: Nicholas Piramal Percentage Revenue, By Geography (2015)

  • Global Narcolepsy Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80
    According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......
  • Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......
  • Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......
  • Migraine Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118
    The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121
    Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......
  • Global Edaravone Market Research Report 2023
    Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......
  • Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......
  • Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs